|
LLNL offers all LLNL workers who are beryllium-associated workers periodic tests for beryllium sensitivity. The tests are offered as a medical examination (either initial or periodic) that includes the Be-LPT or other blood tests for beryllium sensitivity as designated by the LLNL Medical Director. Workers who are, or may become, beryllium-associated workers are encouraged to accept either the Be-LPT or an equivalent designated test. Such workers shall be asked to acknowledge receiving information concerning beryllium sensitization and disease and being offered the beryllium sensitization test. The Health Services Department informs each individual of the test results, including the risks associated with developing CBD, if sensitivity to beryllium is shown. Test results are treated as confidential medical information and are released only with the individual's consent (consistent with current LLNL requirements) or as required by law, including 10 CFR 850 (Chronic Beryllium Prevention Program). Testing for beryllium sensitivity is recommended for all LLNL employees who are beryllium-associated workers and for any LLNL and UC employees transferring to an assignment in a beryllium work area or regulated beryllium work area.
|